Cardiovascular preventative therapies and outcomes of care among urban sub-saharan Africans with type 2 diabetes: A cross-sectional study in Cameroon

Journal of Clinical Outcomes Management

Volumn 19, Issue 10, 2012, Pages 446-452

  Mekong, Joseph O ^a   Kengne, Andre Pascal ^b   Dehayem, Mesmin Yefou ^c   Sobngwi, Eugene ^d   Mbanya, Jean Claude ^d  

^a Université des Montagnes ^*  (Cameroon)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CAMEROON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK REDUCTION; SEDENTARY LIFESTYLE; SMOKING; TREATMENT OUTCOME;

EID: 84867774949     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91. (Pubitemid 351214285)
2. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93. (Pubitemid 36159355)
3. International Diabetes Federation. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes, 2005.
4. Standards of medical care in diabetes - 2011. Diabetes Care 2011;34 Suppl 1:S11-61.
5. Gakidou E, Mallinger L, Abbott-Klafter J, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ 2011;89:172-83.
6. Sobngwi E, Ndour-Mbaye M, Boateng KA, et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa study. Diabetes Res Clin Pract 2011.
7. Kengne AP, Djouogo CF, Dehayem MY, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in cameroon. Int J Low Extrem Wounds 2009;8:180-6.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
10. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
12. Kengne AP, Patel A, Colagiuri S, et al. The Framingham and UKPDS risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010;53:821-31.
13. Crosson JC, Heisler M, Subramanian U, et al. Physicians' perceptions of barriers to cardiovascular disease risk factor control among patients with diabetes: results from the translating research into action for diabetes (TRIAD) study. J Am Board Fam Med 2010;23:171-8.
14. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008;23:588-94.
15. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015-21. (Pubitemid 41110487)
16. Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharm World Sci 2008;30:876-83.
17. Arauz-Pacheco C, Parrott MA, Raskin P. Hypertension management in adults with diabetes. Diabetes Care 2004;27 Suppl 1:S65-7.
18. Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005;31:564-71. (Pubitemid 41187205)
19. Kengne AP, Njamnshi AK, Mbanya JC. Cardiovascular risk reduction in diabetes in sub-Saharan-Africa: What should the priorities be in the absence of global risk evaluation tools? Clin Med Cardiology 2008;2:25-31.
20. International Diabetes Federation. Diabetes atlas. 5th ed. Brussels, 2011.
21. Kengne AP, Amoah AG, Mbanya JC. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 2005;112:3592-601. (Pubitemid 43739537)